Patent · US Active

Thiazolamine derivative and use thereof as anti-picornaviral infection medicament

US9428496B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES · CN

Inventors

Song Li · Beijing, CN
Hongliang Wang · Markham, CA
Junhai Xiao · Beijing, CN
Xian Zhang · Beijing, CN
Lili Wang · Beijing, CN
Zhibing Zheng · Beijing, CN
Wu Zhong · Beijing, CN
Yunde Xie · Beijing, CN
Xingzhou Li · Beijing, CN
Xinbo Zhou · Beijing, CN
Guoming Zhao · Beijing, CN
Xiaokui Wang · Beijing, CN

Key dates

Filing date	Dec 6, 2011
Grant date	Aug 30, 2016
Priority date	—
Expiry date	Oct 11, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is as a substituted thiazolamine derivative represented by Formula I or a pharmaceutically acceptable salt thereof or a hydrate thereof (the definitions of each group in the formula are as presented in the description), and the application thereof in the prevention and/or treatment of viral diseases induced by picornavirus. Also disclosed is a pharmaceutical composition containing the compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.